Savings from parallel import of pharmaceuticals in Finland 2016-2020

The Finnish government is determined to create efficiencies in the market of pharmaceuticals. With this ambition in mind, parallel imports (PI) of pharmaceuticals can be part of the answer. PI is the practice of importing pharmaceuticals from another EU country where they are cheaper than in Finland, a practice has been taking place since the 1970s. In this study, we calculate the savings from parallel imports (PI) of pharmaceuticals in Finland in the period 2016-2020.

The main conclusions of our study are:

The study is commissioned by The Suppliers of Parallel Imported Medicines in Finland.